• mail us help@24marketresearch.com
  • Int'l 1(332) 2424 294 (Int'l)

TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Biopharma Contract Manufacturing Market Research Report 2024(Status and Outlook)

Global Biopharma Contract Manufacturing Market Research Report 2024(Status and Outlook)

  • Category:Energy and Natural Resources
  • Published on : 17 September 2024
  • Pages :122
  • Formats:
  • Report Code:24MRES-7999226
Click for best price

Best Price: $2600

The global Biopharma Contract Manufacturing market was valued at US$ 27.89 billion in 2024 and is projected to reach US$ 49.67 billion by 2030, at a CAGR of 10.1% during the forecast period 2024-2030

Report Overview
This report provides a deep insight into the global Biopharma Contract Manufacturing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biopharma Contract Manufacturing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biopharma Contract Manufacturing market in any manner.
Global Biopharma Contract Manufacturing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

  • Catalent
  • Pharmaceutical Product Development LLC
  • AbbVie
  • Baxter BioPharma Solutions
  • Patheon
  • Grifols International
  • Dalton Pharma Services
  • Boehringer Ingelheim Biopharmaceuticals GmBh
  • Lonza AG.
  • QuintilesIMS
  • Vetter Pharma
  • Ligand Pharmaceuticals, Inc.
  • Bausch Health
  • Recipharm AB
  • Famar Health Care Services
  • West Pharmaceutical Services, Inc.
  • Including or excluding key companies relevant to your analysis.

Market Segmentation (by Type)

  • Manufacturing
  • Research
  • Market Segmentation (by Application)
  • Small Medium Enterprise
  • Large Enterprise

Geographic Segmentation

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Biopharma Contract Manufacturing Market
  • Overview of the regional outlook of the Biopharma Contract Manufacturing Market:

Key Reasons to Buy this Report:

  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biopharma Contract Manufacturing Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

TABLE OF CONTENTS

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Biopharma Contract Manufacturing
1.2 Key Market Segments
1.2.1 Biopharma Contract Manufacturing Segment by Type
1.2.2 Biopharma Contract Manufacturing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Biopharma Contract Manufacturing Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Biopharma Contract Manufacturing Market Competitive Landscape
3.1 Global Biopharma Contract Manufacturing Revenue Market Share by Company (2019-2024)
3.2 Biopharma Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Biopharma Contract Manufacturing Market Size Sites, Area Served, Product Type
3.4 Biopharma Contract Manufacturing Market Competitive Situation and Trends
3.4.1 Biopharma Contract Manufacturing Market Concentration Rate
3.4.2 Global 5 and 10 Largest Biopharma Contract Manufacturing Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Biopharma Contract Manufacturing Value Chain Analysis
4.1 Biopharma Contract Manufacturing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Biopharma Contract Manufacturing Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Biopharma Contract Manufacturing Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biopharma Contract Manufacturing Market Size Market Share by Type (2019-2024)
6.3 Global Biopharma Contract Manufacturing Market Size Growth Rate by Type (2019-2024)
7 Biopharma Contract Manufacturing Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biopharma Contract Manufacturing Market Size (M USD) by Application (2019-2024)
7.3 Global Biopharma Contract Manufacturing Market Size Growth Rate by Application (2019-2024)
8 Biopharma Contract Manufacturing Market Segmentation by Region
8.1 Global Biopharma Contract Manufacturing Market Size by Region
8.1.1 Global Biopharma Contract Manufacturing Market Size by Region
8.1.2 Global Biopharma Contract Manufacturing Market Size Market Share by Region
8.2 North America
8.2.1 North America Biopharma Contract Manufacturing Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biopharma Contract Manufacturing Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biopharma Contract Manufacturing Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biopharma Contract Manufacturing Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biopharma Contract Manufacturing Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Catalent
9.1.1 Catalent Biopharma Contract Manufacturing Basic Information
9.1.2 Catalent Biopharma Contract Manufacturing Product Overview
9.1.3 Catalent Biopharma Contract Manufacturing Product Market Performance
9.1.4 Catalent Biopharma Contract Manufacturing SWOT Analysis
9.1.5 Catalent Business Overview
9.1.6 Catalent Recent Developments
9.2 Pharmaceutical Product Development LLC
9.2.1 Pharmaceutical Product Development LLC Biopharma Contract Manufacturing Basic Information
9.2.2 Pharmaceutical Product Development LLC Biopharma Contract Manufacturing Product Overview
9.2.3 Pharmaceutical Product Development LLC Biopharma Contract Manufacturing Product Market Performance
9.2.4 Pharmaceutical Product Development LLC Biopharma Contract Manufacturing SWOT Analysis
9.2.5 Pharmaceutical Product Development LLC Business Overview
9.2.6 Pharmaceutical Product Development LLC Recent Developments
9.3 AbbVie
9.3.1 AbbVie Biopharma Contract Manufacturing Basic Information
9.3.2 AbbVie Biopharma Contract Manufacturing Product Overview
9.3.3 AbbVie Biopharma Contract Manufacturing Product Market Performance
9.3.4 AbbVie Biopharma Contract Manufacturing SWOT Analysis
9.3.5 AbbVie Business Overview
9.3.6 AbbVie Recent Developments
9.4 Baxter BioPharma Solutions
9.4.1 Baxter BioPharma Solutions Biopharma Contract Manufacturing Basic Information
9.4.2 Baxter BioPharma Solutions Biopharma Contract Manufacturing Product Overview
9.4.3 Baxter BioPharma Solutions Biopharma Contract Manufacturing Product Market Performance
9.4.4 Baxter BioPharma Solutions Business Overview
9.4.5 Baxter BioPharma Solutions Recent Developments
9.5 Patheon
9.5.1 Patheon Biopharma Contract Manufacturing Basic Information
9.5.2 Patheon Biopharma Contract Manufacturing Product Overview
9.5.3 Patheon Biopharma Contract Manufacturing Product Market Performance
9.5.4 Patheon Business Overview
9.5.5 Patheon Recent Developments
9.6 Grifols International
9.6.1 Grifols International Biopharma Contract Manufacturing Basic Information
9.6.2 Grifols International Biopharma Contract Manufacturing Product Overview
9.6.3 Grifols International Biopharma Contract Manufacturing Product Market Performance
9.6.4 Grifols International Business Overview
9.6.5 Grifols International Recent Developments
9.7 Dalton Pharma Services
9.7.1 Dalton Pharma Services Biopharma Contract Manufacturing Basic Information
9.7.2 Dalton Pharma Services Biopharma Contract Manufacturing Product Overview
9.7.3 Dalton Pharma Services Biopharma Contract Manufacturing Product Market Performance
9.7.4 Dalton Pharma Services Business Overview
9.7.5 Dalton Pharma Services Recent Developments
9.8 Boehringer Ingelheim Biopharmaceuticals GmBh
9.8.1 Boehringer Ingelheim Biopharmaceuticals GmBh Biopharma Contract Manufacturing Basic Information
9.8.2 Boehringer Ingelheim Biopharmaceuticals GmBh Biopharma Contract Manufacturing Product Overview
9.8.3 Boehringer Ingelheim Biopharmaceuticals GmBh Biopharma Contract Manufacturing Product Market Performance
9.8.4 Boehringer Ingelheim Biopharmaceuticals GmBh Business Overview
9.8.5 Boehringer Ingelheim Biopharmaceuticals GmBh Recent Developments
9.9 Lonza AG.
9.9.1 Lonza AG. Biopharma Contract Manufacturing Basic Information
9.9.2 Lonza AG. Biopharma Contract Manufacturing Product Overview
9.9.3 Lonza AG. Biopharma Contract Manufacturing Product Market Performance
9.9.4 Lonza AG. Business Overview
9.9.5 Lonza AG. Recent Developments
9.10 QuintilesIMS
9.10.1 QuintilesIMS Biopharma Contract Manufacturing Basic Information
9.10.2 QuintilesIMS Biopharma Contract Manufacturing Product Overview
9.10.3 QuintilesIMS Biopharma Contract Manufacturing Product Market Performance
9.10.4 QuintilesIMS Business Overview
9.10.5 QuintilesIMS Recent Developments
9.11 Vetter Pharma
9.11.1 Vetter Pharma Biopharma Contract Manufacturing Basic Information
9.11.2 Vetter Pharma Biopharma Contract Manufacturing Product Overview
9.11.3 Vetter Pharma Biopharma Contract Manufacturing Product Market Performance
9.11.4 Vetter Pharma Business Overview
9.11.5 Vetter Pharma Recent Developments
9.12 Ligand Pharmaceuticals, Inc.
9.12.1 Ligand Pharmaceuticals, Inc. Biopharma Contract Manufacturing Basic Information
9.12.2 Ligand Pharmaceuticals, Inc. Biopharma Contract Manufacturing Product Overview
9.12.3 Ligand Pharmaceuticals, Inc. Biopharma Contract Manufacturing Product Market Performance
9.12.4 Ligand Pharmaceuticals, Inc. Business Overview
9.12.5 Ligand Pharmaceuticals, Inc. Recent Developments
9.13 Bausch Health
9.13.1 Bausch Health Biopharma Contract Manufacturing Basic Information
9.13.2 Bausch Health Biopharma Contract Manufacturing Product Overview
9.13.3 Bausch Health Biopharma Contract Manufacturing Product Market Performance
9.13.4 Bausch Health Business Overview
9.13.5 Bausch Health Recent Developments
9.14 Recipharm AB
9.14.1 Recipharm AB Biopharma Contract Manufacturing Basic Information
9.14.2 Recipharm AB Biopharma Contract Manufacturing Product Overview
9.14.3 Recipharm AB Biopharma Contract Manufacturing Product Market Performance
9.14.4 Recipharm AB Business Overview
9.14.5 Recipharm AB Recent Developments
9.15 Famar Health Care Services
9.15.1 Famar Health Care Services Biopharma Contract Manufacturing Basic Information
9.15.2 Famar Health Care Services Biopharma Contract Manufacturing Product Overview
9.15.3 Famar Health Care Services Biopharma Contract Manufacturing Product Market Performance
9.15.4 Famar Health Care Services Business Overview
9.15.5 Famar Health Care Services Recent Developments
9.16 West Pharmaceutical Services, Inc.
9.16.1 West Pharmaceutical Services, Inc. Biopharma Contract Manufacturing Basic Information
9.16.2 West Pharmaceutical Services, Inc. Biopharma Contract Manufacturing Product Overview
9.16.3 West Pharmaceutical Services, Inc. Biopharma Contract Manufacturing Product Market Performance
9.16.4 West Pharmaceutical Services, Inc. Business Overview
9.16.5 West Pharmaceutical Services, Inc. Recent Developments
10 Biopharma Contract Manufacturing Regional Market Forecast
10.1 Global Biopharma Contract Manufacturing Market Size Forecast
10.2 Global Biopharma Contract Manufacturing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biopharma Contract Manufacturing Market Size Forecast by Country
10.2.3 Asia Pacific Biopharma Contract Manufacturing Market Size Forecast by Region
10.2.4 South America Biopharma Contract Manufacturing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biopharma Contract Manufacturing by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Biopharma Contract Manufacturing Market Forecast by Type (2025-2030)
11.2 Global Biopharma Contract Manufacturing Market Forecast by Application (2025-2030)
12 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biopharma Contract Manufacturing Market Size Comparison by Region (M USD)
Table 5. Global Biopharma Contract Manufacturing Revenue (M USD) by Company (2019-2024)
Table 6. Global Biopharma Contract Manufacturing Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharma Contract Manufacturing as of 2022)
Table 8. Company Biopharma Contract Manufacturing Market Size Sites and Area Served
Table 9. Company Biopharma Contract Manufacturing Product Type
Table 10. Global Biopharma Contract Manufacturing Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Biopharma Contract Manufacturing
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Biopharma Contract Manufacturing Market Challenges
Table 18. Global Biopharma Contract Manufacturing Market Size by Type (M USD)
Table 19. Global Biopharma Contract Manufacturing Market Size (M USD) by Type (2019-2024)
Table 20. Global Biopharma Contract Manufacturing Market Size Share by Type (2019-2024)
Table 21. Global Biopharma Contract Manufacturing Market Size Growth Rate by Type (2019-2024)
Table 22. Global Biopharma Contract Manufacturing Market Size by Application
Table 23. Global Biopharma Contract Manufacturing Market Size by Application (2019-2024) & (M USD)
Table 24. Global Biopharma Contract Manufacturing Market Share by Application (2019-2024)
Table 25. Global Biopharma Contract Manufacturing Market Size Growth Rate by Application (2019-2024)
Table 26. Global Biopharma Contract Manufacturing Market Size by Region (2019-2024) & (M USD)
Table 27. Global Biopharma Contract Manufacturing Market Size Market Share by Region (2019-2024)
Table 28. North America Biopharma Contract Manufacturing Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Biopharma Contract Manufacturing Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Biopharma Contract Manufacturing Market Size by Region (2019-2024) & (M USD)
Table 31. South America Biopharma Contract Manufacturing Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Biopharma Contract Manufacturing Market Size by Region (2019-2024) & (M USD)
Table 33. Catalent Biopharma Contract Manufacturing Basic Information
Table 34. Catalent Biopharma Contract Manufacturing Product Overview
Table 35. Catalent Biopharma Contract Manufacturing Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Catalent Biopharma Contract Manufacturing SWOT Analysis
Table 37. Catalent Business Overview
Table 38. Catalent Recent Developments
Table 39. Pharmaceutical Product Development LLC Biopharma Contract Manufacturing Basic Information
Table 40. Pharmaceutical Product Development LLC Biopharma Contract Manufacturing Product Overview
Table 41. Pharmaceutical Product Development LLC Biopharma Contract Manufacturing Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Pharmaceutical Product Development LLC Biopharma Contract Manufacturing SWOT Analysis
Table 43. Pharmaceutical Product Development LLC Business Overview
Table 44. Pharmaceutical Product Development LLC Recent Developments
Table 45. AbbVie Biopharma Contract Manufacturing Basic Information
Table 46. AbbVie Biopharma Contract Manufacturing Product Overview
Table 47. AbbVie Biopharma Contract Manufacturing Revenue (M USD) and Gross Margin (2019-2024)
Table 48. AbbVie Biopharma Contract Manufacturing SWOT Analysis
Table 49. AbbVie Business Overview
Table 50. AbbVie Recent Developments
Table 51. Baxter BioPharma Solutions Biopharma Contract Manufacturing Basic Information
Table 52. Baxter BioPharma Solutions Biopharma Contract Manufacturing Product Overview
Table 53. Baxter BioPharma Solutions Biopharma Contract Manufacturing Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Baxter BioPharma Solutions Business Overview
Table 55. Baxter BioPharma Solutions Recent Developments
Table 56. Patheon Biopharma Contract Manufacturing Basic Information
Table 57. Patheon Biopharma Contract Manufacturing Product Overview
Table 58. Patheon Biopharma Contract Manufacturing Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Patheon Business Overview
Table 60. Patheon Recent Developments
Table 61. Grifols International Biopharma Contract Manufacturing Basic Information
Table 62. Grifols International Biopharma Contract Manufacturing Product Overview
Table 63. Grifols International Biopharma Contract Manufacturing Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Grifols International Business Overview
Table 65. Grifols International Recent Developments
Table 66. Dalton Pharma Services Biopharma Contract Manufacturing Basic Information
Table 67. Dalton Pharma Services Biopharma Contract Manufacturing Product Overview
Table 68. Dalton Pharma Services Biopharma Contract Manufacturing Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Dalton Pharma Services Business Overview
Table 70. Dalton Pharma Services Recent Developments
Table 71. Boehringer Ingelheim Biopharmaceuticals GmBh Biopharma Contract Manufacturing Basic Information
Table 72. Boehringer Ingelheim Biopharmaceuticals GmBh Biopharma Contract Manufacturing Product Overview
Table 73. Boehringer Ingelheim Biopharmaceuticals GmBh Biopharma Contract Manufacturing Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Boehringer Ingelheim Biopharmaceuticals GmBh Business Overview
Table 75. Boehringer Ingelheim Biopharmaceuticals GmBh Recent Developments
Table 76. Lonza AG. Biopharma Contract Manufacturing Basic Information
Table 77. Lonza AG. Biopharma Contract Manufacturing Product Overview
Table 78. Lonza AG. Biopharma Contract Manufacturing Revenue (M USD) and Gross Margin (2019-2024)
Table 79. Lonza AG. Business Overview
Table 80. Lonza AG. Recent Developments
Table 81. QuintilesIMS Biopharma Contract Manufacturing Basic Information
Table 82. QuintilesIMS Biopharma Contract Manufacturing Product Overview
Table 83. QuintilesIMS Biopharma Contract Manufacturing Revenue (M USD) and Gross Margin (2019-2024)
Table 84. QuintilesIMS Business Overview
Table 85. QuintilesIMS Recent Developments
Table 86. Vetter Pharma Biopharma Contract Manufacturing Basic Information
Table 87. Vetter Pharma Biopharma Contract Manufacturing Product Overview
Table 88. Vetter Pharma Biopharma Contract Manufacturing Revenue (M USD) and Gross Margin (2019-2024)
Table 89. Vetter Pharma Business Overview
Table 90. Vetter Pharma Recent Developments
Table 91. Ligand Pharmaceuticals, Inc. Biopharma Contract Manufacturing Basic Information
Table 92. Ligand Pharmaceuticals, Inc. Biopharma Contract Manufacturing Product Overview
Table 93. Ligand Pharmaceuticals, Inc. Biopharma Contract Manufacturing Revenue (M USD) and Gross Margin (2019-2024)
Table 94. Ligand Pharmaceuticals, Inc. Business Overview
Table 95. Ligand Pharmaceuticals, Inc. Recent Developments
Table 96. Bausch Health Biopharma Contract Manufacturing Basic Information
Table 97. Bausch Health Biopharma Contract Manufacturing Product Overview
Table 98. Bausch Health Biopharma Contract Manufacturing Revenue (M USD) and Gross Margin (2019-2024)
Table 99. Bausch Health Business Overview
Table 100. Bausch Health Recent Developments
Table 101. Recipharm AB Biopharma Contract Manufacturing Basic Information
Table 102. Recipharm AB Biopharma Contract Manufacturing Product Overview
Table 103. Recipharm AB Biopharma Contract Manufacturing Revenue (M USD) and Gross Margin (2019-2024)
Table 104. Recipharm AB Business Overview
Table 105. Recipharm AB Recent Developments
Table 106. Famar Health Care Services Biopharma Contract Manufacturing Basic Information
Table 107. Famar Health Care Services Biopharma Contract Manufacturing Product Overview
Table 108. Famar Health Care Services Biopharma Contract Manufacturing Revenue (M USD) and Gross Margin (2019-2024)
Table 109. Famar Health Care Services Business Overview
Table 110. Famar Health Care Services Recent Developments
Table 111. West Pharmaceutical Services, Inc. Biopharma Contract Manufacturing Basic Information
Table 112. West Pharmaceutical Services, Inc. Biopharma Contract Manufacturing Product Overview
Table 113. West Pharmaceutical Services, Inc. Biopharma Contract Manufacturing Revenue (M USD) and Gross Margin (2019-2024)
Table 114. West Pharmaceutical Services, Inc. Business Overview
Table 115. West Pharmaceutical Services, Inc. Recent Developments
Table 116. Global Biopharma Contract Manufacturing Market Size Forecast by Region (2025-2030) & (M USD)
Table 117. North America Biopharma Contract Manufacturing Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Europe Biopharma Contract Manufacturing Market Size Forecast by Country (2025-2030) & (M USD)
Table 119. Asia Pacific Biopharma Contract Manufacturing Market Size Forecast by Region (2025-2030) & (M USD)
Table 120. South America Biopharma Contract Manufacturing Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Biopharma Contract Manufacturing Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Global Biopharma Contract Manufacturing Market Size Forecast by Type (2025-2030) & (M USD)
Table 123. Global Biopharma Contract Manufacturing Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Industrial Chain of Biopharma Contract Manufacturing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biopharma Contract Manufacturing Market Size (M USD), 2019-2030
Figure 5. Global Biopharma Contract Manufacturing Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Biopharma Contract Manufacturing Market Size by Country (M USD)
Figure 10. Global Biopharma Contract Manufacturing Revenue Share by Company in 2023
Figure 11. Biopharma Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Biopharma Contract Manufacturing Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Biopharma Contract Manufacturing Market Share by Type
Figure 15. Market Size Share of Biopharma Contract Manufacturing by Type (2019-2024)
Figure 16. Market Size Market Share of Biopharma Contract Manufacturing by Type in 2022
Figure 17. Global Biopharma Contract Manufacturing Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Biopharma Contract Manufacturing Market Share by Application
Figure 20. Global Biopharma Contract Manufacturing Market Share by Application (2019-2024)
Figure 21. Global Biopharma Contract Manufacturing Market Share by Application in 2022
Figure 22. Global Biopharma Contract Manufacturing Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Biopharma Contract Manufacturing Market Size Market Share by Region (2019-2024)
Figure 24. North America Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Biopharma Contract Manufacturing Market Size Market Share by Country in 2023
Figure 26. U.S. Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Biopharma Contract Manufacturing Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Biopharma Contract Manufacturing Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Biopharma Contract Manufacturing Market Size Market Share by Country in 2023
Figure 31. Germany Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Biopharma Contract Manufacturing Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Biopharma Contract Manufacturing Market Size Market Share by Region in 2023
Figure 38. China Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Biopharma Contract Manufacturing Market Size and Growth Rate (M USD)
Figure 44. South America Biopharma Contract Manufacturing Market Size Market Share by Country in 2023
Figure 45. Brazil Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Biopharma Contract Manufacturing Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Biopharma Contract Manufacturing Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Biopharma Contract Manufacturing Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Biopharma Contract Manufacturing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Biopharma Contract Manufacturing Market Share Forecast by Type (2025-2030)
Figure 57. Global Biopharma Contract Manufacturing Market Share Forecast by Application (2025-2030)

SELECT A FORMAT

USD GBP EURO YEN Single User License
USD GBP EURO YEN Multi User License
USD GBP EURO YEN Corporate User License

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy
check discount